Both in Biotechnology
ImmunityBio vs Kymera Therapeutics
Over the past year IBRX returned +243.6% and KYMR returned +88.9%; their daily moves had a correlation of 0.14.
IBRX +243.6% KYMR +88.9%Growth of $1, one year, split-adjusted
| Metric | IBRX | KYMR |
|---|---|---|
| Price | $8.83 | $110.51 |
| Market cap | $9.36B | $9.19B |
| Today | +3.64% | −1.33% |
| 1 month | +9.7% | −6.5% |
| 6 months | +32.6% | +39.0% |
| Year to date | +346.0% | +42.0% |
| 1 year | +247.6% | +96.5% |
| Revenue growth (YoY) | +93.9% | +466.4% |
| Gross margin | 99.4% | 100.0% |
| Net margin | −449.6% | −94.2% |
| P/E (TTM) | — | — |
| Price / sales | 56.4× | 87.5× |
| Net cash | -$57.7M | $688.6M |
| Dividend yield | — | — |
| Volatility (60d) | 60.5% | 41.5% |
| Short % of float | 31.7% | 17.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).